Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank
MIAMI, March 2, 2015 /PRNewswire/ -- Vivex Biomedical, Inc., a leading processor of human tissue, synthetics, mimetic patterning technology, and biocellular products, announced today that it hired Lou Barnes as President and Chief Operating Officer of UMTB Biomedical, Inc. Vivex Biomedical formed UMTB Biomedical as a wholly-owned subsidiary to acquire the University of Miami Tissue Bank (UMTB) in November 2014. UMTB is the oldest tissue bank in the country.
Mr. Barnes is a twenty-five year veteran of the tissue banking industry, having most recently served as Executive Director of DCI Donor Services Tissue Bank, Inc. in Nashville, Tennessee. Prior to DCI, Mr. Barnes worked with other leading tissue banks, both in the for-profit and not-for-profit sectors. Mr. Barnes is the current Chair of American Association of Tissue Banks (AATB) Processing & Distribution Council and a member of AATB's Board of Governors.
"We are extremely excited to have Lou and his wife, Teri, join the Vivex family of companies. His leadership skills and high level of expertise add to the growing pool of talent we are bringing to our tissue bank in Miami, Florida," stated Tracy Anderson, President and CEO of Vivex Biomedical, Inc.
Regarding his new role, Mr. Barnes states, "This is an exciting opportunity to join Vivex Biomedical, a leading company in the tissue banking industry, and work with a talented team to bring new allograft forms to patients in need. Vivex develops technology platforms that will maximize the gift of tissue donation through advancements in regenerative medicine."
Comments and questions for Vivex can be directed to Michael Rozmajzl, General Counsel, at (770) 575 5221.
About Vivex: Vivex Biomedical, Inc. is a privately held company based out of Marietta, Georgia focused on cellular therapies that treat orthopaedic, spine, wound and soft tissue indications. Vivex and its wholly owned subsidiary, UMTB Biomedical, own and hold exclusive rights to proprietary technologies in the field of biomedicine, stem cells, and orthopaedic implant surface modification. The Vivex Biomedical technology includes marrow isolated adult multilineage inducible (MIAMI) cell identification and processing, as well as, mimetic patterning technologies (MIME) which can improve the efficiency and efficacy of a patient's healing cascade and reduce the overall cost of healthcare.
About UMTB: Founded in 1970 through a partnership with the U.S. Naval Hospital in Bethesda, MD, the UMTB tissue bank is the oldest tissue bank in the United States. Vivex Biomedical and UMTB Biomedical maintain a close working relationship with the University of Miami in the field of tissue banking. UMTB has been led by H. Thomas Temple, M.D., a world renowned orthopaedic oncologist and surgeon at the University of Miami.
Safe Harbor Statements. This press release contains forward-looking statements. These forward-looking statements are based on our current assumptions, expectations, and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties, and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, without limitation, factors affecting our financial results, demand for our products, our ability to obtain regulatory clearance or approval, where necessary, from the U.S. Food and Drug Administration, our ability to compete successfully, our ability to safeguard our intellectual property, and our ability to comply with laws and regulations that are or may become applicable to our businesses. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements.
SOURCE Vivex Biomedical, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article